Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lichen planopilaris is rare, mostly affects older women, and is often linked to autoimmune diseases like lupus.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

Acitretin effectively treats severe hypertrophic lichen planus.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

Frontal fibrosing alopecia can occur with lichen planus pigmentosus, needing careful diagnosis and treatment.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

lncRNAs are important for understanding and treating skin diseases.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The case shows the need for psychiatrists to manage end-of-life care for dementia patients, including respecting patients' wishes and using hospice services.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

The P&P Hairline Laser is a new, hands-free device that improves hairline symmetry in hair restoration surgery and can create a symmetrical hairline in less than a minute.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

People with lichen planus are more likely to have abnormal blood fats than healthy people.

Both environmental and genetic factors contribute to Lichen Planopilaris.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

Photobiomodulation Therapy (PBMT) is recommended as a more inclusive term and shows potential benefits in various treatments.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Abrocitinib may effectively treat Lichen Planopilaris.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.